Talk about a reversal of fortunes Three years after being heralded as the fastest drug launch ever and quickly racking up  billion in sales the Incivek hepatitis C treatment will be discontinued this coming October by Vertex Pharmaceuticals The move is unlikely to come as a surprise though given the steep decline in Incivek sales over the past year Even before Gilead Sciences last January began selling its rival Sovaldi treatment which boasts a  cure rate Incivek sales had been plummeting